Ichor’s TriGrid® Delivery System is a technologically superior, clinically tested, integrated and automated electroporation system capable of enhanced, tolerable and reproducible nucleic acid administration in a manner capable of supporting drug commercialization. The TriGrid technology has been licensed by companies such as Pfizer and Janssen to deliver their proprietary DNA vaccines. Ichor has also received funding from the US government for DNA-based antibody delivery. Ichor continues to seek strategic partnerships to provide the TriGrid technology to partners interested in expanding their product pipeline in nucleic acid-based biologics.
Dramatic potency of nucleic acid products compared to conventional injection
From Concept to Commercial
Established manufacturing and device support for every phase of development
Patented Automated Design
Strong IP protection covering device designed for user independent administration procedure with single button activation